Concepedia

Ojas S. Wagal

OS

Statistics

Publications

1

Citations

10

H-Index

1

Active since

2021

Affiliations

Pharmaceutical Product Development (India)(Current)

Ojas S. Wagal is an author at Pharmaceutical Product Development (India) specializing in molecular docking, cyclin-dependent kinase inhibitors, and molecular docking analysis.

ORCID

Publications per year

2021–2021

1

Publications

1

Evaluation of Benzamide-Chalcone Derivatives as EGFR/CDK2 Inhibitor: Synthesis,In-Vitro Inhibition, and Molecular Modeling Studies

Akshada Joshi, Heena Bhojwani, Ojas S. Wagal et al. · Anti-Cancer Agents in Medicinal Chemistry · 2021 · 10 citations

, , +16

1–1 of 1